Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine pharmacokinetics in intensive care patients with subarachnoid hemorrhage
NL-OMON21573Active, not recruiting
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nimodipine in subarachnoid hemorrhage (SAH), sponsored by none. Primary endpoints: Pharmacokinetics of nimodipine and Variability of oral bioavailability of nimodipine. Started Dec 2006; status: active, not recruiting.
02
Drugs
nimodipine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NL-OMON21573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21573.